# FDA Inspection 1102975 - R & B Medical Group Inc. - September 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/1acd6768-6233-4e27-ad0a-c9be895a012a
Source feed: FDA_Inspections

> FDA Inspection 1102975 for R & B Medical Group Inc. on September 25, 2019. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102975
- Company Name: R & B Medical Group Inc.
- Inspection Date: 2019-09-25
- Classification: Official Action Indicated (OAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1150365 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/a692c375-f1e0-43c1-985e-b9b1d88a9cb7)
- [FDA Inspection 1150365 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/7f9c3e97-b8ba-42e5-b532-27825033581d)
- [FDA Inspection 1102975 - 2019-09-25](https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/456a9d98-111a-4607-ae74-5f45133e76e2)
- [FDA Inspection 977932 - 2016-06-14](https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/2eeb68ff-474e-4280-b03c-217730324bca)

Company: https://www.keypedia.com/companies/r-b-medical-group-inc/cfc94659-cdd7-4462-af33-36be815fbee0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d